Google
×
Past week
  • Any time
  • Past hour
  • Past 24 hours
  • Past week
  • Past month
  • Past year
All results
Rating (943)
3 days ago · Amil é condenada a fornecer Kisqali® (Ribociclibe) e Seletiv® (Fulvestranto) após negativa de cobertura a paciente com câncer.
Rating (943)
3 days ago · SulAmérica Saúde é condenada a reembolsar paciente por negativa de cobertura do medicamento Mabthera® (Rituximabe).
In order to show you the most relevant results, we have omitted some entries very similar to the 2 already displayed. If you like, you can repeat the search with the omitted results included.